Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Management of Patients With Graves’ Orbitopathy: Initial Assessment, Management Outside Specialised Centres and Referral Pathways
source: Clinical Medicine: Journal of the Royal College of Physicians of London
year: 2015
authors: Perros P, Dayan CM, Dickinson AJ, Ezra D, Estcourt S, Foley P, Hickey J, Lazarus JH, MacEwen CJ, McLaren J, Rose GE, Uddin J, Vaidya B
summary/abstract:Graves’ orbitopathy (GO) is uncommon, but responsible for considerable morbidity. A coordinated approach between healthcare professionals is required in order to meet the needs of patients. Early diagnosis can be achieved by a simple clinical assessment. Low-cost effective interventions can be initiated by generalists, which may improve outcomes. Moderate-to-severe GO should be referred to specialised centres. Recommendations for clinical diagnosis, initial management and referral pathways are highlighted.
organization: Newcastle upon Tyne, UK; Cardiff University, UK; Moorfields Eye Hospital, UK; Royal Devon and Exeter Hospital, UK; British Thyroid Foundation, UK; Ninewells Hospital, UKDOI: 10.7861/clinmedicine.15-2-173
read more full text
Related Content
-
Manejo Quirúrgico de la Enfermedad de Graves• La tiroidectomía puede considerarse...
-
Drug Versus Radioactive Treatment of Graves’ Disease – Metabolic OutcomesBackground: Weight gain is a common com...
-
Thyrotropin Receptor Antibody Levels at Diagnosis and After Thionamide Course Predict Graves’ Disease RelapseBackground: Thionamides are associated ...
-
Teprotumumab for the Treatment of Active Thyroid Eye DiseaseBackground: Thyroid eye disease is a de...
-
Stress Triggers the Onset and the Recurrences of Hyperthyroidism in Patients With Graves’ DiseaseThe aim of this study was to evaluate th...
-
Early Use of Steroid-Sparing Agents in the Inactivation of Moderate-to-Severe Active Thyroid eye DiseaseObjectives: The current first-line trea...
-
Jennifer A. Sivak Callcott, MDJennifer A Sivak-Callcott is an Oculofac...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.